NCT06742476

Brief Summary

During general anesthesia, the administration of anesthetics and muscle relaxants induces apnea, wherein spontaneous breathing ceases . Pediatric patients, characterized by their higher oxygen consumption rate and smaller functional residual capacity, are particularly susceptible to hypoxemia during apneic episodes . This vulnerability to hypoxemia underscores the critical need for effective oxygenation strategies during anesthesia. Apneic oxygenation, the provision of oxygen without concurrent tidal volume delivery, emerges as a vital technique in pediatric anesthesia, playing a pivotal role in both routine and challenging airway management scenarios . In modern practice, apneic oxygenation during airway management denotes the uninterrupted supply of oxygen, extending the window for maintaining safe oxygen saturation levels during the apneic phase . This technique holds particular significance in pediatric patients undergoing adenotonsillectomy, where the delicate balance of oxygenation is paramount . Adenotonsillectomy, a common surgical procedure in pediatric patients, poses unique challenges in airway management . The procedure involves the removal of the adenoids and tonsils, often necessitating general anesthesia and temporary airway obstruction . Furthermore, the potential for blood and secretions in the oropharynx increases the risk of airway compromise during the perioperative period. In this context, ensuring adequate oxygenation is essential to mitigate the risk of hypoxemia and its associated complications In this randomized clinical trial, the investigators aim to evaluate the efficacy and safety of apneic oxygenation using nasal cannula in pediatric patients undergoing adenotonsillectomy under general anesthesia. By assessing our primary outcome and secondary outcomes, the investigators seek to contribute valuable insights into optimizing anesthesia management protocols for this vulnerable patient population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

December 15, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 19, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

December 8, 2025

Status Verified

December 1, 2025

Enrollment Period

7 months

First QC Date

December 12, 2024

Last Update Submit

December 4, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Lowest oxygen saturation during tracheal intubation.

    Following intubation, SpO2 levels will be recorded

    at the end of intubation procedure

Secondary Outcomes (7)

  • Number of patients that their spo2 dropped to 95%.

    at the end of intubation procedure

  • Number of patients that their spo2 dropped to 92%.

    at the end of intubation procedure

  • Number of patients that their spo2 dropped to below 92%.

    at the end of intubation procedure

  • Spo2 base line Spo2 after bag and mask ventillation and Spo2 immediately after intubation.

    at the end of intubation procedure

  • Number of intubation attempts.

    at the end of intubation procedure

  • +2 more secondary outcomes

Study Arms (2)

control group

NO INTERVENTION

Patients in the group A will undergo tracheal intubation without apneic oxygenation

apniec oxygenation group

EXPERIMENTAL

Patients in the group B will undergo tracheal intubation in addition to apneic oxygenation at a flow 0.2 mg/kg using nasal cannula

Device: nasal cannula

Interventions

In the apneic oxygenation group, nasal cannula will be employed to administer continuous oxygenation, utilizing a flow rate of 0.2 L/kg, during the apneic phase while tracheal intubation is performed. Successful intubation will be confirmed by auscultation and the appearance of a square wave capnogragh.

apniec oxygenation group

Eligibility Criteria

Age3 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patients (3 - 10 Years).
  • Patients who were scheduled for adenotonsillectomy.
  • ASA I and II

You may not qualify if:

  • When nasal intubation is needed.
  • Patients reported with nasal obstruction.
  • Patients with any respiratory disease like asthma or recent upper respiratory tract infection.
  • Patients with obstructive sleep apnea
  • Patients with congenital heart disease
  • Patients suspected difficult intubation or syndromatic patients eg : down syndrome , Goldenhar Syndrome , Pierre Robin syndrome … etc

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fayoum University Hospital

Al Fayyum, Egypt

Location

Related Publications (10)

  • Bhananker SM, Ramamoorthy C, Geiduschek JM, Posner KL, Domino KB, Haberkern CM, Campos JS, Morray JP. Anesthesia-related cardiac arrest in children: update from the Pediatric Perioperative Cardiac Arrest Registry. Anesth Analg. 2007 Aug;105(2):344-50. doi: 10.1213/01.ane.0000268712.00756.dd.

    PMID: 17646488BACKGROUND
  • van Munster JJCM, Zamanipoor Najafabadi AH, Schoones JW, Peul WC, van den Hout WB, van Benthem PPG. The impact of new evidence on regional variation in paediatric tonsillectomy and adenoidectomy: a historical review. J Laryngol Otol. 2020 Dec;134(12):1036-1043. doi: 10.1017/S002221512000273X.

    PMID: 33431080BACKGROUND
  • Noda M, Shimada MD, Koshu R, Saito C, Ito M. Efficacy of endoscopic powered intracapsular tonsillectomy and adenoidectomy for pediatric obstructive sleep apnea: A retrospective case-control study. Auris Nasus Larynx. 2023 Jun;50(3):383-388. doi: 10.1016/j.anl.2022.08.008. Epub 2022 Sep 7.

    PMID: 36085267BACKGROUND
  • Randall DA. Current Indications for Tonsillectomy and Adenoidectomy. J Am Board Fam Med. 2020 Nov-Dec;33(6):1025-1030. doi: 10.3122/jabfm.2020.06.200038.

    PMID: 33219085BACKGROUND
  • Soneru CN, Hurt HF, Petersen TR, Davis DD, Braude DA, Falcon RJ. Apneic nasal oxygenation and safe apnea time during pediatric intubations by learners. Paediatr Anaesth. 2019 Jun;29(6):628-634. doi: 10.1111/pan.13645. Epub 2019 Apr 29.

    PMID: 30943324BACKGROUND
  • Olayan L, Alatassi A, Patel J, Milton S. Apnoeic oxygenation by nasal cannula during airway management in children undergoing general anaesthesia: a pilot randomised controlled trial. Perioper Med (Lond). 2018 Feb 21;7:3. doi: 10.1186/s13741-018-0083-x. eCollection 2018.

    PMID: 29484172BACKGROUND
  • Lyons C, Callaghan M. Uses and mechanisms of apnoeic oxygenation: a narrative review. Anaesthesia. 2019 Apr;74(4):497-507. doi: 10.1111/anae.14565. Epub 2019 Feb 19.

    PMID: 30784037BACKGROUND
  • Kleine-Brueggeney M, Grosshauser M, Greif R. Apneic oxygenation in pediatric anesthesia. Curr Opin Anaesthesiol. 2022 Jun 1;35(3):361-366. doi: 10.1097/ACO.0000000000001127.

    PMID: 35671025BACKGROUND
  • Nimmagadda U, Salem MR, Crystal GJ. Preoxygenation: Physiologic Basis, Benefits, and Potential Risks. Anesth Analg. 2017 Feb;124(2):507-517. doi: 10.1213/ANE.0000000000001589.

    PMID: 28099321BACKGROUND
  • Tiradentes TAA, Einav S, Braz JRC, Nunes-Nogueira VS, Betini M, Corrente JE, Braz MG, Braz LG. Global anaesthesia-related cardiac arrest rates in children: a systematic review and meta-analysis. Br J Anaesth. 2023 Nov;131(5):901-913. doi: 10.1016/j.bja.2023.08.023. Epub 2023 Sep 22.

MeSH Terms

Conditions

Airway Obstruction

Interventions

Cannula

Condition Hierarchy (Ancestors)

Respiratory InsufficiencyRespiration DisordersRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

CathetersEquipment and Supplies

Study Officials

  • Safaa Gaber Ragab, MD

    Faculty of medicine, Fayoum university

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor of anaesthiology

Study Record Dates

First Submitted

December 12, 2024

First Posted

December 19, 2024

Study Start

December 15, 2024

Primary Completion

June 30, 2025

Study Completion

June 30, 2025

Last Updated

December 8, 2025

Record last verified: 2025-12

Locations